The United States cartilage degeneration market is estimated to advance with a CAGR of 5.01% during the forecasting years. The market growth of the country is influenced by factors such as the surging incidence of arthritis, the increasing number of sports injuries, as well as the growing geriatric population. The base year considered for the studied market is 2020, and the forecasted years are from 2021 to 2026.

UNITED STATES CARTILAGE DEGENERATION MARKET FORECAST 2021-2026

United States Cartilage Degeneration Market by Procedure (Joint Replacement, Chondroplasty, Cell-based Cartilage Resurfacing, Osteochondral Transplant, Meniscus Transplants, Other Procedures) Market by Application (Knee, Hips, Other Applications) Market by End-user (Ambulatory Surgical Centers, Hospitals & Specialty Clinics, Academic & Research Institutes)

Request free sample

The United States cartilage degeneration market is estimated to advance with a CAGR of 5.01% during the forecasting years. The market growth of the country is influenced by factors such as the surging incidence of arthritis, the increasing number of sports injuries, as well as the growing geriatric population. The base year considered for the studied market is 2020, and the forecasted years are from 2021 to 2026.united-states-cartilage-degeneration-market

To learn more about this report, request a free sample copy

Cartilage plays a pivotal role in the smooth mechanical movements of muscles and bones. However, the degeneration of cartilage can result in significant pain and chronic joint inflammation. Besides, the injured cartilage can potentially impact the quality of life, as well. Continual research and development efforts are being established towards the innovation of novel methodologies and techniques to deal with cartilage damage. These include joint replacement, chondroplasty, cell therapies, and others.

According to the Centers for Disease Control and Prevention, approximately 23% of the United States population suffers from arthritis. Hence, the increasing prevalence of the condition is set to augment the need for procedures that treat cartilage degeneration. In addition, sports injuries may also lead to cartilage damage, resultant in joint pain, swelling, and stiffness. Therefore, these factors are anticipated to drive the United States cartilage degeneration market over the forecast period.

Arthex Inc, headquartered in the United States, is a medical device firm distributing various products in the field of orthopedics. It operates through numerous segments such as hand and wrist, shoulder, knee, elbow, foot and ankle, resection, orthobiologics, imaging, and others. The company also provides a diverse range of advanced products associated with blood plasma.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • COUNTRY SNAPSHOT
      • COUNTRY ANALYSIS
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
    3. KEY ANALYTICS
      • IMPACT OF COVID-19 ON CARTILAGE DEGENERATION MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRY
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    4. MARKET BY PROCEDURE
      • JOINT REPLACEMENT
      • CHONDROPLASTY
      • CELL-BASED CARTILAGE RESURFACING
      • OSTEOCHONDRAL TRANSPLANT
      • MENISCUS TRANSPLANTS
      • OTHER PROCEDURES
    5. MARKET BY APPLICATION
      • KNEE
      • HIPS
      • OTHER APPLICATIONS
    6. MARKET BY END-USER
      • AMBULATORY SURGICAL CENTERS
      • HOSPITALS & SPECIALTY CLINICS
      • ACADEMIC & RESEARCH INSTITUTES
    7. ACADEMIC & RESEARCH INSTITUTESCOMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
        • BUSINESS EXPANSIONS/ APPROVALS/ ANNOUNCEMENTS
      • COMPANY PROFILES
        • ANIKA THERAPEUTICS INC
        • ARTHREX INC
        • CONMED CORPORATION
        • DEPUY SYNTHES COMPANIES
        • STRYKER CORPORATION
        • ZIMMER BIOMET HOLDINGS

    LIST OF TABLES  

    TABLE 1: MARKET SNAPSHOT – CARTILAGE DEGENERATION

    TABLE 2: UNITED STATES CARTILAGE DEGENERATION MARKET, BY PROCEDURE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 3: UNITED STATES CARTILAGE DEGENERATION MARKET, BY PROCEDURE, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 4: UNITED STATES CARTILAGE DEGENERATION MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: UNITED STATES CARTILAGE DEGENERATION MARKET, BY APPLICATION, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 6: UNITED STATES CARTILAGE DEGENERATION MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: UNITED STATES CARTILAGE DEGENERATION MARKET, BY END-USER, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 8: UNITED STATES CARTILAGE DEGENERATION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: UNITED STATES CARTILAGE DEGENERATION MARKET, BY COUNTRY, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 10: LIST OF MERGERS & ACQUISITIONS

    TABLE 11: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 12: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 13: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

    LIST OF FIGURES 

    FIGURE 1: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 2: OPPORTUNITY MATRIX

    FIGURE 3: VENDOR LANDSCAPE

    FIGURE 4: UNITED STATES CARTILAGE DEGENERATION MARKET, BY PROCEDURE, IN 2020

    FIGURE 5: UNITED STATES CARTILAGE DEGENERATION MARKET, BY JOINT REPLACEMENT, 2021-2026 (IN $ MILLION)

    FIGURE 6: UNITED STATES CARTILAGE DEGENERATION MARKET, BY CHONDROPLASTY, 2021-2026 (IN $ MILLION)

    FIGURE 7: UNITED STATES CARTILAGE DEGENERATION MARKET, BY CELL-BASED CARTILAGE RESURFACING, 2021-2026 (IN $ MILLION)

    FIGURE 8: UNITED STATES CARTILAGE DEGENERATION MARKET, BY OSTEOCHONDRAL TRANSPLANT, 2021-2026 (IN $ MILLION)

    FIGURE 9: UNITED STATES CARTILAGE DEGENERATION MARKET, BY MENISCUS TRANSPLANTS, 2021-2026 (IN $ MILLION)

    FIGURE 10: UNITED STATES CARTILAGE DEGENERATION MARKET, BY OTHER PROCEDURES, 2021-2026 (IN $ MILLION)

    FIGURE 11: UNITED STATES CARTILAGE DEGENERATION MARKET, BY APPLICATION, IN 2020

    FIGURE 12: UNITED STATES CARTILAGE DEGENERATION MARKET, BY KNEE, 2021-2026 (IN $ MILLION)

    FIGURE 13: UNITED STATES CARTILAGE DEGENERATION MARKET, BY HIPS, 2021-2026 (IN $ MILLION)

    FIGURE 14: UNITED STATES CARTILAGE DEGENERATION MARKET, BY OTHER APPLICATIONS, 2021-2026 (IN $ MILLION)

    FIGURE 15: UNITED STATES CARTILAGE DEGENERATION MARKET, BY END-USER, IN 2020

    FIGURE 16: UNITED STATES CARTILAGE DEGENERATION MARKET, BY AMBULATORY SURGICAL CENTERS, 2021-2026 (IN $ MILLION)

    FIGURE 17: UNITED STATES CARTILAGE DEGENERATION MARKET, BY HOSPITALS & SPECIALTY CLINICS, 2021-2026 (IN $ MILLION)

    FIGURE 18: UNITED STATES CARTILAGE DEGENERATION MARKET, BY ACADEMIC & RESEARCH INSTITUTES, 2021-2026 (IN $ MILLION)

    1. MARKET BY PROCEDURE
      • JOINT REPLACEMENT
      • CHONDROPLASTY
      • CELL-BASED CARTILAGE RESURFACING
      • OSTEOCHONDRAL TRANSPLANT
      • MENISCUS TRANSPLANTS
      • OTHER PROCEDURES
    2. MARKET BY APPLICATION
      • KNEE
      • HIPS
      • OTHER APPLICATIONS
    3. MARKET BY END-USER
      • AMBULATORY SURGICAL CENTERS
      • HOSPITALS & SPECIALTY CLINICS
      • ACADEMIC & RESEARCH INSTITUTES

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type